References

Atkinson, A., Daniels, C., Dedrick, R., Grudzinskas, C., Markey, S. (2001). Principles of Clinical Pharmacology. San Diego: Academic Press.

Anderson, S., Hauck W.W. (1996). "The transitivity of bioequivalence testing: potential for drift." International Journal of Clinical Pharmacology and Therapeutics. 34, 369–374.

Barrett, J.S., Batra, V., Chow, A., Cook, J., Gould, A.L., Heller, A., Lo, MW., Patterson, S.D., Smith, B.P., Stritar, J.A., Vega, J.M., Zariffa, N. (2000). "PhRMA Perspective on Population and Individual Bioequivalence and Update to the PhRMA Perspective on Population and Individual Bioequivalence." Journal of Clinical Pharmacology. 40, 561–572.

Benet, L.Z. (1999). "Understanding Bioequivalence Testing." Transplantation Proceedings. 31, Supplement 1, 7S–9S.

Box, G.E., Cox, D.R. (1964). "An analysis of transformations." Journal of the Royal Statistical Society, Series B. 26, 211–243.

Chow, S.C., Liu, J. (2000). Design and Analysis of Bioavailability and Bioequivalence Studies, second edition. New York: Marcel Dekker.

Crow, E.L., Shimizu, K. (1988). Lognormal distributions. New York: Marcel Dekker.

FDA Guidance. (1992). Statistical procedures for bioequivalence studies using a standard two treatment cross-over design.

FDA Guidance. (February, 1999). Guidance for Industry: Population Pharmacokinetics.

FDA Guidance. (January, 2001). Guidance for Industry: Statistical Approaches to Establishing Bioequivalence.

FDA Guidance. (April, 2003). Guidance for Industry: Exposure-Response Relationships—Study Design, Data Analysis, and Regulatory Applications.

Hauck, W.W., Anderson S. (1992). "Types of bioequivalence and related statistical considerations." International Journal of Clinical Pharmacology, Therapy, and Toxicology. 30, 181–187.

Hauck, W.W., Hyslop, T., Anderson, S., Bois, F.Y., Tozer, T.N. (1995). "Statistical and regulatory considerations for multiple measures in bioequivalence testing." Clinical Research and Regulatory Affairs. 12, 249–265.

Hauschke, D., Steinijans, V.W., Diletti, E. (1990). "A distribution free procedure for the statistical analysis of bioequivalence studies." International Journal of Clinical Pharmacology, Therapy, and Toxicology. 28, 72–78.

Hinkelmann, K., Kempthorne, O. (1994). Design and Analysis of Experiments, Volume I: Introduction to Experimental Design. New York: Wiley.

Jones, B., Kenward M.G. (2003). Design and Analysis of Cross-over Trials, second edition. London: Chapman and Hall.

Julious, S., Debarnot, C. A-M. (1999). "Why are pharmacokinetic data summarized by arithmetic means?" Journal of Biopharmaceutical Statistics. 10, 55–71.

Kenward, M., Roger, J. (1997). "Small sample inference for fixed effects from restricted maximum likelihood." Biometrics. 33, 983–997.

Lacey, L.F., Keene, O.N., Bye, A. (1995). "Glaxo's immediate release and extended release dosage forms." Drug Information Journal. 29, 821–840.

Lacey, L.F., Keene, O.N., Pritchard, J.F., Bye, A. (1997). "Common noncompartmental pharmacokinetic variables: are they normally or log-normally distributed?" Journal of Biopharmaceutical Statistics. 7, 171–178.

Machado, S., Miller, R., Hu, C. (1999). "A regulatory perspective on pharmacokinetic and pharmacodynamic modelling." Statistical Methods in Medical Research. 8, 217–45.

Milliken, G.A., Johnson, D.E. (1992). Analysis of Messy Data, Volume 1: Designed Experiments, New York: Chapman and Hall.

Patterson, H.D. (1950). "The construction of balanced designs for experiments involving sequences of treatments." Biometrika . 39, 32.

Patterson, H.D., Thompson, R. (1971). "Recovery of Inter-block information when block sizes are unequal." Biometrika. 58, 545–554.

Patterson, S.D. (2001). "A review of the development of biostatistical design and analysis techniques for assessing in vivo bioequivalence, Part 1." Indian Journal of Pharmaceutical Sciences. 63, 81–100.

Patterson, S.D., Jones, B. (2002). "Bioequivalence and the pharmaceutical industry." Pharmaceutical Statistics. 1, 83–95.

Patterson, S.D., Jones, B. (2004). "Simulation assessments of statistical aspects of bioequivalence in the pharmaceutical industry." Pharmaceutical Statistics. 3, 13–23.

Rowland, M., Tozer, T.N. (1980). Clinical Pharmacokinetics Concepts and Applications. Philadelphia: Lea and Febiger.

Schuirmann, D.J. (1987). "A comparison of the two one sided tests procedure and the power approach for assessing the equivalence of average bioavailability." Journal of Pharmacokinetics and Biopharmaceutics. 15, 657–680.

Senn, S. (2002) Cross-over Trials in Clinical Research, second edition. New York: John Wiley & Sons.

Sheiner L.B., Beal, S.L., Sambol, N.C. (1989). "Study Designs for Dose-Ranging." Clinical Pharmacology and Therapeutics. 46, 63–77.

Sheiner, L.B. (1997). "Learning versus confirming in clinical drug development." Clinical Pharmacology and Therapeutics. 61, 275–291.

Sheiner, L.B., Steimer, J-L. (2000). "Pharmacokinetic-pharmacodynamic modeling in drug development." Annual Reviews of Pharmacology and Toxicology. 40, 67–95.

Smith, B., Vandenhende, F.R., DeSante, K., Farid, N., Welch, P., Callaghan, J., Forgue, S. (2000). "Confidence interval criteria for assessment of dose proportionality." Pharmaceutical Research. 17, 1278–1283.

Smith, B.P. (2004). "Assessment of Dose Proportionality." Chapter 6, Part 2 of Pharmacokinetics in Drug Development: Clinical Study Design and Analysis, Volume 1. Bonate, P., Howard, D., editors. Arlington,VA: AAPS Press. 363–382.

Vonesh, E.F., Chinchilli, V.M. (1997). Linear and Nonlinear models for the analysis of repeated measurements. New York: Marcel Dekker.

Wellek, S. (2003) Testing Statistical Hypotheses of Equivalence. London: Chapman and Hall.

Westlake, W.J. (1986). "Bioavailability and bioequivalence of pharmaceutical formulations." Biopharmaceutical Statistics for Drug Development. K. Peace, editor. New York: Marcel Dekker. 329–352.

Yeh, K.C., Kwan, K.C. (1978). "A comparison of numerical integrating algorithms of trapezoidal, Legrange, and spline approximation." Journal of Pharcokinetics and Biopharmaceutics. 6, 79–81.

Zariffa, N.M-D., Patterson, S.D. (2001). "Population and Individual Bioequivalence: Lessons from Real Data and Simulation Studies." Journal of Clinical Pharmacology. 41, 811–822.